Home | Welcome to Contract Pharma   
Last Updated Sunday, November 23 2014
Print

Search Results for 'Preclinical Outsourcing'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Characterizing the Cost of Non-Clinical Development Activity
By Stella Stergiopoulos, Jennifer Kim, Kenneth Getz, Tufts CSDD
Published June 5, 2013
Understanding a critical R&D segment Read More »
Outsourcing Preclinical and Clinical Work
By KR Karu, Sparta Systems
Published May 6, 2013
Focus on quality! Read More »
Resizing the Global Contract R&D Services Market
By Kenneth Getz, Mary Jo Lamberti, Adam Mathias, Stella Stergiopoulos, Tufts CSDD
Published May 30, 2012
A new study revises estimates of the market Read More »
By Steve Snyder
Published January 23, 2012
The realities of preclinical drug development Read More »
By Steve Snyder
Published October 11, 2011
My answers to Frequently Asked Questions Read More »
Preclinical Outsourcing Report
By Jay Mehta
Published September 7, 2011
Long-term and more collaborative contracts to optimize cost structures Read More »
By Steve Snyder
Published July 13, 2011
Excerpts from some favorite past articles Read More »
By Steve Snyder
Published October 12, 2006
Insight from an industry veteran Read More »
Virtual Outsourcing
By Linda Comp, Telerx
Published September 5, 2013
The ACA affects regulatory outsourcing Read More »
CRO Outlook & Market Trends
By Kristin Brooks, Contract Pharma
Published June 5, 2013
Innovation tied to globalization & collaboration Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On